Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: October 2015

HHS Awards $2.2 Billion in Ryan White Grants for HIV/AIDS Care And Medications

Ryan WhiteWashington, DC, October 21, 2015 — Health and Human Services Secretary Sylvia M. Burwell announced today that more than $2.2 billion in Ryan White HIV/AIDS Program grants was awarded in fiscal year (FY) 2015 to cities, states and local community-based organizations.

This funding supports a coordinated and comprehensive system of care to ensure that more than half a million people living with and affected by HIV in the United States continue to have access to critical HIV health care, support services, and essential medications.

The program is named in honor of the late Ryan White, who — along with his mother, Jeanne White Ginder — fought AIDS-related discrimination and helped educate the nation and world about his disease. Continue reading

American Cancer Society Releases New Breast Cancer Guideline; Urge Annual Mammograms at 45

American Cancer Society logoAtlanta, GA, October 21, 2015 — The American Cancer Society yesterday released new guidelines for breast cancer screening.  Among the changes, the new recommendations say all women should begin having yearly mammograms at age 45, and can change to having mammograms every other year beginning at age 55.

The guidelines were published October 20, 2015 in the Journal of the American Medical Association.

The guideline is the first created since the Society incorporated Institute of Medicine standards into its guideline development protocol to ensure a more rigorous and transparent process for developing and communicating guidelines. Continue reading

Rowan University Researchers Announce Blood-based Biomarkers for Early Detection, Diagnosis and Staging of Parkinson’s

Rowan University logoStratford, NJ, October 21, 2015 — In a study involving nearly 400 subjects, researchers from the Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., have demonstrated that a blood test they developed can detect early-stage Parkinson’s disease.

Using human protein microarrays, the researchers identified a panel of blood-borne autoantibodies that act as potential biomarkers to detect early-stage Parkinson’s disease with an overall accuracy of 87.9 percent (94.1 percent sensitivity and 85.5 percent specificity), and an accuracy rate of 97.5 percent in differentiating between early and mild-moderate stages of the disease. Continue reading

Rutgers Genetics Research Center Awarded $6 Million Federal Grant

New Brunswick, NJ, October 20, 2015 — The National Institute of Neurological Disorders and Stroke (NINDS) has awarded a five-year U24 grant worth up to $6,034,323 to RUCDR Infinite Biologics, a unit of Rutgers’ Human Genetics Institute of New Jersey. RUCDR, which is located on Rutgers’ Busch Campus in Piscataway, is the world’s largest university-based biorepository.

With the new grant, the Rutgers operation will take over management of the NINDS stem cell repository.

RUCDR also will provide a comprehensive range of stem-cell related services including derivation and quality control of induced Pluripotent Stem Cells (iPSCs), to researchers throughout the world investigating diseases including Parkinson’s, amyotrophic lateral sclerosis (ALS), and Huntington’s. Continue reading

PhRMA Member Companies Invested $51.2 Billion in R&D in 2014; Over $600 Billion Since 2000

Research 1Washington, DC, October 19, 2015 ― Pharmaceutical Research and Manufacturers of America’s (PhRMA) in April announced that member companies invested an estimated $51.2 billion last year in the research and development (R&D) of new innovative treatments and cures.  The figure represents the majority of all biopharmaceutical R&D spending — both public and private — in the United States.

The new R&D numbers, the result of a recent survey of PhRMA member companies, are highlighted in the newly released PhRMA 2015 Biopharmaceutical Research Industry Profile as well as a new industry chart pack, Biopharmaceuticals in Perspective. Continue reading

TODAY! Event: Rutgers Cancer Institute to Host Symposium on Cancer-Treatment ‘Pipeline’ October 19

Rutgers CINJ LogoNew Brunswick, NJ, October 19, 2015Rutgers Cancer Institute of New Jersey will host a “what’s-in-the-pipeline” symposium with industry from 4:00 to 6:00 p.m. in Auditorium A and B at 195 Little Albany Street in New Brunswick.

Co-sponsored by the HealthCare Institute of New Jersey (HINJ), the forum is designed to foster collaboration and networking between Rutgers faculty and strategic industry partners.

Attendees will have an update on drugs in the development pipeline at Merck & Co. and industry executives will hear about basic clinical investigations at Rutgers.  Continue reading

Medicare Recipients Face Higher Drug-Plan Costs, Other Changes

Washington, DC, October 18, 2015 — Anne Tergesen reported in The Wall Street Journal that the big news for Medicare beneficiaries this week is about 2016 costs for Part B: 70% of beneficiaries won’t see any change in premiums for this coverage of doctor visits and other outpatient care.

But, for the remainder, 2016 charges could rise 52% unless Congress or the Obama administration steps in to provide relief.

Meanwhile, other changes are coming in 2016 and later years for participants in the federal health insurance program for people ages 65 and older. Here are three areas to be aware of: Continue reading

Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers

Prescription RxWashington, DC, October 17, 2015 ― The Partnership for Prescription Assistance (PPA), a nationwide effort sponsored by America’s biopharmaceutical research companies, earlier this year unveiled a redesigned website with new features and functionality to provide patients and caregivers with faster, easier access to information on more than 475 public and private patient assistance programs.

Since its launch in 2005, PPA has provided a platform to engage, educate and empower patients and caregivers to access more information about their prescription assistance options. PPA has connected more than 9 million Americans who are uninsured or lack adequate health care coverage to programs that provide prescription medicines for free or nearly free. Continue reading

Johns Hopkins Researchers Develop Epilepsy Seizure-Symptom App

Apple Store roundBaltimore, MD, October 16, 2015 — In what may be the coolest medical-innovation story of the day, Zachary Tracer reports for Bloomberg that, someday soon, Apple Inc.’s iPhones and new Apple watches may be able to recognize when someone’s having an epileptic seizure, and call for help.

Johns Hopkins University researchers have developed an app that can track and measure seizure symptoms, and is the first research app to combine sensors on both Apple’s watch and phone.  Eventually, it may run in the background and alert caregivers that a patient is having an event.  Continue reading

HHS Forecast: 10 Million People Expected to Have Obamacare Coverage End of 2016

Healthcare America 2Washington, DC, October 16, 2015 — U.S. Health and Human Services (HHS) Secretary Sylvia M. Burwell announced yesterday that she expects 10 million individuals to be enrolled in coverage through the Health Insurance Marketplaces and paying their premiums — so-called effectuated coverage — at the close of 2016.

As part of that goal, HHS believes more than 1 out of every 4 uninsured Marketplace-eligible consumers will select plans during Open Enrollment. Continue reading